Rouhana, S.;                     Virsolvy, A.;                     Fares, N.;                     Richard, S.;                     Thireau, J.    
        Ranolazine: An Old Drug with Emerging Potential; Lessons from Pre-Clinical and Clinical Investigations for Possible Repositioning. Pharmaceuticals 2022, 15, 31.
    https://doi.org/10.3390/ph15010031
    AMA Style
    
                                Rouhana S,                                 Virsolvy A,                                 Fares N,                                 Richard S,                                 Thireau J.        
                Ranolazine: An Old Drug with Emerging Potential; Lessons from Pre-Clinical and Clinical Investigations for Possible Repositioning. Pharmaceuticals. 2022; 15(1):31.
        https://doi.org/10.3390/ph15010031
    
    Chicago/Turabian Style
    
                                Rouhana, Sarah,                                 Anne Virsolvy,                                 Nassim Fares,                                 Sylvain Richard,                                 and Jérôme Thireau.        
                2022. "Ranolazine: An Old Drug with Emerging Potential; Lessons from Pre-Clinical and Clinical Investigations for Possible Repositioning" Pharmaceuticals 15, no. 1: 31.
        https://doi.org/10.3390/ph15010031
    
    APA Style
    
                                Rouhana, S.,                                 Virsolvy, A.,                                 Fares, N.,                                 Richard, S.,                                 & Thireau, J.        
        
        (2022). Ranolazine: An Old Drug with Emerging Potential; Lessons from Pre-Clinical and Clinical Investigations for Possible Repositioning. Pharmaceuticals, 15(1), 31.
        https://doi.org/10.3390/ph15010031